An observational study in Poly Cystic Ovary Treatment for Infertility, sponsored by Sohag University. Status unknown at 1 site in Egypt. Open to female participants. Per ClinicalTrials.gov, last updated 2023-01-26.
Sponsored by Sohag University · Observational
The study will focus on treatment of Poly Cystic Ovary Syndrome patients with infertility The aim is to to find the best treatment by comparison of surgical and non surgical intervention
INTRODUCTION Infertility is the failure of couples to conceive after one year of having regular unprotected coitus 1, 2\&3 Globally there are 48 -186 million people cases reported with infertility. The common causes of infertility are being male factor, tubal peritoneal factor, cervical mucus, an ovulatory disorders and others causes including anti-sperm antibodies, luteal phase deficiency, diabetic mellitus, genital tract infection 1,2\&4 Infertility is often multifactorial so during treatment multiple investigations should be conducted 2 Anovulation cover 30% of all infertility cases, is a complex process by which there is a failure of ovary to release mature ovarian follicles and involves a lot of potential causes 2\&5 The clinical symptoms of anovulating cycles are irregular periods, light or heavy menses, deficiency of cervical mucus, Irregular Basal Body Temperature (BBT) 2\&5 The common causes of anovulatory cycle is Polycystic Ovarian Syndrome (PCOS), other causes are due to hypothalamus or pituitary gland dysfunction, Premature ovarian failure, high serum estradiol in follicular phase, age above 45, hyper prolactinemia, subclinical hypothyroidism, drugs, luteinized unruptured follicles, Diabetes mellitus, athletic activity and people who do not eat and become very slim 1,2\&5 Polycystic Ovarian Syndrome (PCOS) is a condition in a female of child bearing age characterized by menstrual disorders, hyperandrogenism, multiple ovarian cysts and anovulatory cycle 6 The causes of this condition are idiopathic, but the following reasons are highly suggested to be associated with PCO 6\&7 Insulin resistance develop from excess insulin lead the body to produce more androgen and causing anovulatory cycle 6 women with PCOS have low grade inflammation that stimulates Poly cystic ovaries to produce androgen which can lead changes in blood vessels and heart 6 PCOS also may be due familiar susceptibility 6 The sign and symptoms of PCO are Menstrual disorders including missed period more than 35 days, infrequent period less 9 menses in a year, irregular menses light or heavy period 6\&7 Hyperandrogenism manifestation like hirsutism, clitoromegaly, masculinization, severe acne, in severe form of PCO (hyperthecosis) there is deepening of voice 6, 7\&8 History of infertility due to intermittently ovulation, the condition also is associate with higher chance of miscarriage 8 Polycystic ovaries presence of numerous small cysts filled with fluid in the ovaries 6\&7 Majority of PCO patients are obese which worsen the symptoms of PCO 6\&8 About 10 % of PCO cases have type 2 Diabetic Mellitus and 30-40 % at age of 40 have impaired glucose tolerance test 8 Sleep apnea which predispose PCO affected patients to cardiovascular disease 8 COMPLICATION OF PCO Infertility, gestational diabetes, Pregnancy induce hypertension, abortion or pre term birth, steatohepatitis, cardiovascular disease, Type 2 diabetes or prediabetes, lack of sleep, depression, thinning of hair, anxiety and eating disorder, abnormal uterine bleeding, acanthosis nigricans, armpit and under breasts, endometrial cancer a1 a2 The treatment of PCO is widely including life style modification, drug treatment, FDA safety alerts, metabolic derangements, anovulation, hirsutism, diet and activity, surgical intervention a3
73 studies on the registry are indexed under Ovarian Cysts; 15 are open to participants now.
This study's planned enrollment of 150 is close to the median of 160 across 25 observational studies indexed under Ovarian Cysts.
Browse Ovarian Cysts studies →Sohag University is the lead sponsor of 1,183 studies on the registry; 612 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Women in a child bearing age with poly cystic ovarian syndrome
Exclusion Criteria:
laparoscopic drilling response in Poly Cystic Ovary case
Procedure: laparoscopic drilling
induction,Anti estrogen,Insulin sensitizing agent, Aromatase Inhibitor,Gonadotropin
Other: Non Surgical treatment
Life style modification response in Poly Cystic Ovary case for treatment of infertility
Behavioral: Treatment of Poly cystic ovary for infertility by Life style modification
Assisted reproductive technique response in Poly Cystic Ovary case for treatment of infertility
Procedure: Treatment of Poly cystic ovary for infertility by Assisted reproductive technique
Controlling menstrual disorders response in Poly Cystic Ovary case for treatment of infertility
Other: Non Surgical treatment
Cutaneous manifestation response in Poly Cystic Ovary case for treatment of infertility
Other: Non Surgical treatment
Non Surgical
Also known as: Induction, Aromatase inhibitor,Insulin sensitizing agent,Gonadotropin,Anti estrogen
Surgical intervension
Non Surgical
Also known as: Non surgical treatment option
Surgical intervention
Also known as: Surgical treatment option
The rate of ovulation after life modification
The study will focus on different methods of health modification like health eating, exercise and weight loss and their ability to keep hormones in normal ranges and cause ovulation
Time frame: 6 months
Rate of ovulation by medical treatment like Clomifene Citrate and Letrozole
The study also will focus on different medical treatment method like Clomifene Citrate, lentrozole for induction in ovulation
Time frame: 6 months
Rate of regular ovulation after laparoscopic Ovarian drilling (Surgical treatment)
The surgery is done to remove part of ovary through laparoscopy which results ovary to restore normal ovulation
Time frame: 6 months
Plan to share: Undecided
No publications or documents are linked to this record.
This study is status unknown, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sohag University